BCAA, also known as Branched Chain Amino Acids, is made up of three amino acids: L-Leucine, L-Lsoleucine and L-Valine. It provides the basis for protein synthesis and energy production, and is commonly used in sports nutrition to improve exercise performance and to reduce protein and muscle breakdown during exercise. Though it’s considered safe, some are convinced it has potentially dangerous health effects.
What Is Branched Chain Amino Acids?
Branched Chain Amino Acid(BCAA) is an amino acid having aliphatic side-chains with a branch (a carbon atom bound to more than two other carbon atoms). This product is one of the essential amino acids in the human body that affects muscles.There are three varieties of Branched Chain Amino Acids: leucine, isoleucine and valine. Dietary BCAA supplementation can increase metabolic rate in the body.
Possible Side Effects of Branched Chain Amino Acids
Although Branched Chain Amino Acids generally regarded as a very safe and effective supplement, there can be some minor side effects. The side effects may:
- fatigue and loss of coordination.
GRAS Affirmation: Yes
Generally recognized as safe (GRAS) is an American Food and Drug Administration (FDA) designation that a chemical or substance added to food is considered safe by experts, and so is exempted from the usual Federal Food, Drug, and Cosmetic Act (FFDCA) food additive tolerance requirements. Branched Chain Amino Acids is considered safe.
Suggested Dosage
NA.
Special Populations Precaution
There is a lot of concern about diet and nutrition for these population, like Newborns, children, pregnant, sensitive to Branched Chain Amino Acids populations. Better consult to your doctor if you would like to intake Branched Chain Amino Acids.
Related Research
1. Pre-, peri-, and postoperative oral administration of branched-chain amino acids for primary liver cancer patients for hepatic resection: a systematic review. [Nutr Cancer. 2014] Author: Meng J, Zhong J, Zhang H, Zhong W, Huang Z, Jin Y, Xu J.
2. Branched-chain amino acids and amyotrophic lateral sclerosis: a treatment failure? The Italian ALS Study Group. [Neurology. 1993 Dec] Author: [No authors listed]
3. Long-term treatment of latent portosystemic encephalopathy with branched-chain amino acids. A double-blind placebo-controlled crossover study. [J Hepatol. 1993 Mar] Author: Plauth M, Egberts EH, Hamster W, Török M, Müller PH, Brand O, Fürst P, Dölle W.